Read the full story: #Psychedelics #MentalHealthInnovation #DepressionTreatment To view or add a comment, sign in #TreatableTraitTalks The slip between cup and lip is well endorsed if not entrenched as clinical reality Drug resistant epilepsy or #DRE management is challenging for the choice of complementary drugs especially when the traits are omnious as psychiatric comorbidities or comedications that hamper the therapeutic relevance of High dose #Levetiracetam that is often employed for #GTCS cases The recent #ULTIMATE publication as Longitudinal research further mirrors the clinical dissect and delight for comprehensive control of Seizure Frequency with Lacosamide coadministration The mechanistic delight offered by Lacosamide as that sVGSC, CRMP n GABAa modulator makes it ideal choice as #Adjuvant therapy in clinical #Phenotypes of GTCS with or without DRE variaton that calms hyperexcitable neurons The clinical synergy is well highlighted by the first addon advantage for Lacosamide with High dose Levetiracetam

And I guess with that, the holiday pounds
Common side effects include nausea, vomiting, constipation, diarrhoea, stomach upset, heartburn, excessive belching, dizziness, headaches and fatigue
Muneeb Ullah, orcid.org/0009-0007-9150-7796
Semaglutide is particularly beneficial for: Individuals with Type 2 diabetes and early signs of kidney disease
DermaVue Face-Saver Protocol Month 1